15 minutes agoO OVS accidentally publishes a document on the anti-coronvirus drug
Periskopi(6 years ago)
(6 years ago)A potential antiviral anti - coronary drug has reportedly failed in its first clinical test. There was a lot of hope that Remdesivivir could treat patients with Avid-19, but a test in China showed that the drug had not been successful, according to the draft document published accidentally by the World Health Organization. Medication did not improve [...]
There was a lot of hope that Remdesivivir could treat patients with Avid-19, but a test in China showed that the drug had not been successful, according to the draft document published accidentally by the World Health Organization.
Medication did not improve the condition of patients or reduce the presence of pathogen in the bloodstream, O points out BSH.
However, the American firm behind the medicine. Gilead Sciences said the document had badly characterised the study.
O BSH has eliminated the study on Remdesiviri, which proved to be over 200 Coronavirus infected, of which 14% lost their lives.
Clinical trials were interrupted because of the side effects of the drug in question. But days ago, a Chicago hospital treated numerous patients with Remdesivir, whose condition improved within 14 days. This prompted the hope of widespread use that was shattered by the World Health Organization's recommendation.
